Germany · Biotechnology startup
Germany · Lux Biosciences
Lux Biosciences is a biotechnology company developing medicines for the treatment of ophthalmic diseases.
Funding reportedLast round: Debt financing
What company datasets say Lux Biosciences raised
Funding, as reported
Reported in all129.2Min the source's currency
Rounds8
Last roundDebt financing
Last round dateMar 2012
Investors listed4
Biotechnology in Germany
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Lux Biosciences in front of investors. Or tell us what we have wrong.